As reported by Genetic Engineering and Biotechnology News, there has been a growth in the development and manufacturing of biotherapeutics in the UK. In addition, the UK is showing a strong pipeline for biopharmaceutical development.
At the recent biotech conference, bioProcessUK, Head of bioProcessUK at the HealthTech and Medicines Knowledge Transfer Network, Mark Bustard stated, “This year we estimate at least 500 new jobs have been created in bioprocessing . Our current government is recognizing that we have to encourage new types of industry. So it’s investing in bioprocess manufacturing with Technology Strategy Board funding of £8.5 million to fund regenerative medicine projects alone.”
Biotherapeutics in the UK:
A number of companies are looking at increasing their capacity for the development and manufacturing of biotherapeutics in the UK. Including, GlaxoSmithKline, Lonza, Fujifilm Diosynth Biotechnologies and Eden Biodesign.
Biopharmaceutical development in the UK:
According to Dr. Bustard, the U.K. has at least 205 innovative medicines in development with companies such as Reneuron making good progress with its cellular therapy to treat stroke patients.